en
Scientific article
English

Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma

Published inDigestive and Liver Disease, vol. 49, no. 5, p. 552-556
Publication date2017
Abstract

Perioperative chemotherapy improves the prognosis of patients with locoregionally advanced resectable gastric and gastro-esophageal junction adenocarcinoma. Nevertheless, only 50% of operated patients could receive the postoperative component chemotherapy. An exclusive preoperative chemotherapy is therefore an interesting strategy. We report the clinical course of patients with operable gastric and gastroesophageal junction adenocarcinoma treated with an intention of exclusive preoperative chemotherapy.

Citation (ISO format)
FERNANDEZ, Eugenio et al. Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma. In: Digestive and Liver Disease, 2017, vol. 49, n° 5, p. 552–556. doi: 10.1016/j.dld.2016.12.025
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1590-8658
475views
1downloads

Technical informations

Creation05/11/2017 11:55:00 AM
First validation05/11/2017 11:55:00 AM
Update time03/15/2023 1:40:58 AM
Status update03/15/2023 1:40:57 AM
Last indexation01/16/2024 11:56:32 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack